Biomarker for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

  • Prognostic marker
  • Diabetic nephropathy marker
  • Molecular markers for both metabolic syndrome and hypoglycemia response
  • Genetic lifestyle interaction in the development and prevention of diabetes

Related Conference of Biomarker for Diabetes

September 28-29, 2018

2nd International Conference on Diabetes and Diabetic Nursing Care

Montreal, Quebec, Canada
November 21-22, 2018

14th World Congress on Endocrinology & Diabetes

Paris, France
November 26-27, 2018

26th International Diabetes and Healthcare Conference

Helsinki, Finland
November 26-27, 2018

13th European Diabetes and Endocrinology Congress

Dublin, Ireland

March 28-29, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 16-17, 2019

2nd Global Meeting on Diabetes and Endocrinology

Abu Dhabi, UAE

28th European Diabetes Congress

June 10-11, 2019 | Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Biomarker for Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in